Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-03-03 Sale | 2026-03-05 8:00 pm | Olema Pharmaceuticals Inc. | OLMA | Mitchell Shawnte CHIEF LEGAL OFFICER | 39,767 | $23.78 | $945,750 | 845,000 (Direct) | View |
| 2026-01-20 Sale | 2026-01-21 9:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 10,000 | $26.88 | $268,800 | 844,798 (Indirect Direct) | View |
| 2026-01-14 Sale | 2026-01-16 9:00 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 3,489 | $29.12 | $101,600 | 854,798 (Indirect Direct) | View |
| 2026-01-13 Sale | 2026-01-15 9:00 pm | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 103,822 | $28.7 | $2,980,054 | 139,727 (Direct) | View |
| 2026-01-12 Sale | 2026-01-14 9:30 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 110,000 | $28.25 | $3,107,229 | 850,438 (Indirect Direct) | View |
| 2025-12-22 Sale | 2025-12-29 9:55 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 2,881 | $28.53 | $82,195 | 858,287 (Indirect Direct) | View |
| 2025-12-19 Sale | 2025-12-23 9:42 pm | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 264,800 | $29.73 | $7,873,109 | 12,080 (Direct) | View |
| 2025-12-19 Sale | 2025-12-23 9:41 pm | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 51,000 | $30.46 | $1,553,544 | 710,558 (Indirect Direct) | View |
| 2025-12-19 Sale | 2025-12-23 9:40 pm | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem Chief Medical Officer | 269,509 | $27.94 | $7,530,148 | 635,306 (Direct) | View |
| 2025-09-16 Sale | 2025-09-18 9:30 pm | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 25,000 | $8.1936 | $204,841 | 861,168 (Indirect Direct) | View |
| 2025-01-10 Sale | 2025-01-14 6:38 pm | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 420,000 | $0 | $0 | 6,854,528 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-28 Option Award | 2026-04-29 7:53 pm | N/A 2036-04-27 | Olema Pharmaceuticals Inc. | OLMA | Raman Prakash Director | 27,061 | $0 | 27,061 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 8:00 pm | N/A 2035-02-27 | Olema Pharmaceuticals Inc. | OLMA | Mitchell Shawnte CHIEF LEGAL OFFICER | 40,000 | $0 | 845,000 (Direct) | View |
| 2026-03-03 Exercise | 2026-03-05 8:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Mitchell Shawnte CHIEF LEGAL OFFICER | 40,000 | $4.37 | 845,000 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-17 9:35 pm | N/A 2036-02-01 | Olema Pharmaceuticals Inc. | OLMA | Austin Sasha Lu VP of Finance and Controller | 40,950 | $0 | 45,438 (Direct) | View |
Ownership | 2026-02-17 9:33 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Austin Sasha Lu VP of Finance and Controller | 0 | $0 | 142,488 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 9:30 pm | N/A 2036-02-01 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 356,250 | $0 | 356,250 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 9:30 pm | N/A 2036-02-01 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 356,250 | $0 | 356,250 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 9:30 pm | N/A 2036-02-01 | Olema Pharmaceuticals Inc. | OLMA | Mitchell Shawnte CHIEF LEGAL OFFICER | 276,250 | $0 | 276,250 (Direct) | View |
| 2026-02-02 Option Award | 2026-02-04 9:30 pm | N/A 2036-02-01 | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 1,125,000 | $0 | 1,125,000 (Direct) | View |
| 2026-01-13 Exercise | 2026-01-14 9:30 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 100,000 | $4.87 | 850,438 (Direct) | View |
| 2026-01-13 Exercise | 2026-01-14 9:30 pm | N/A 2033-01-31 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 100,000 | $0 | 850,438 (Direct) | View |
| 2025-12-26 Gift | 2025-12-30 4:05 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean President and CEO | 8,500 | $0 | 237,650 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:42 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 21,520 | $7.84 | 12,080 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:42 pm | N/A 2023-08-11 | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 264,800 | $0 | 12,080 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:42 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 12,070 | $4.08 | 12,080 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:42 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 209,690 | $4.406 | 12,080 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:42 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 21,520 | $3.61 | 12,080 (Direct) | View |
| 2025-12-19 Gift | 2025-12-23 9:41 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 9,000 | $0 | 710,558 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:40 pm | N/A 2034-01-31 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem Chief Medical Officer | 140,000 | $0 | 635,306 (Direct) | View |
| 2025-12-22 Exercise | 2025-12-23 9:40 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem Chief Medical Officer | 57,182 | $7.02 | 635,306 (Direct) | View |
| 2025-12-19 Exercise | 2025-12-23 9:40 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem Chief Medical Officer | 82,818 | $15.25 | 635,306 (Direct) | View |
| 2025-12-08 Gift | 2025-12-09 9:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 75,000 | $0 | 243,549 (Direct) | View |
| 2025-11-26 Gift | 2025-12-01 9:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 225,000 | $0 | 318,549 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-25 6:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 35,868 | $0.39 | 385,965 (Direct) | View |
| 2025-11-21 Exercise | 2025-11-25 6:00 pm | N/A 2025-12-20 | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 35,868 | $0 | 385,965 (Direct) | View |
| 2025-11-25 Gift | 2025-11-25 6:00 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 35,868 | $0 | 385,965 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 6:23 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 24,150 | $0 | 11,538,621 (Indirect) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | Garland J. Scott Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | Horning Sandra Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | CLARK IAN T Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | Hrustanovic Gorjan Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | Graham G. Walmsley Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | Harmon Cyrus Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | BUTITTA CYNTHIA M Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 5:00 pm | N/A 2035-06-11 | Olema Pharmaceuticals Inc. | OLMA | RAPPAPORT ANDREW Director | 24,150 | $0 | 24,150 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-03 4:20 pm | N/A 2035-02-27 | Olema Pharmaceuticals Inc. | OLMA | Myles David C. CH. DISCOV. & NON-CLIN DEV OFF | 205,000 | $0 | 205,000 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-03 4:19 pm | N/A 2035-02-27 | Olema Pharmaceuticals Inc. | OLMA | Zojwalla Naseem CHIEF MEDICAL OFFICER | 205,000 | $0 | 205,000 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-03 4:18 pm | N/A 2035-02-27 | Olema Pharmaceuticals Inc. | OLMA | Mitchell Shawnte CHIEF LEGAL OFFICER | 450,000 | $0 | 450,000 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-03 4:16 pm | N/A 2035-02-27 | Olema Pharmaceuticals Inc. | OLMA | Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. | 320,000 | $0 | 320,000 (Direct) | View |
| 2025-02-28 Option Award | 2025-03-03 4:15 pm | N/A 2035-02-27 | Olema Pharmaceuticals Inc. | OLMA | Bohen Sean PRESIDENT AND CEO | 650,000 | $0 | 650,000 (Direct) | View |
| 2025-01-10 Option Award | 2025-01-14 6:38 pm | N/A N/A | Olema Pharmaceuticals Inc. | OLMA | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BVF I GP LLC BIOTECHNOLOGY VALUE FUND II LP BVF II GP LLC Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF GP HOLDINGS LLC BVF INC LAMPERT MARK N See Explanation of Responses | 420,000 | $0 | 6,854,528 (Direct) | View |